Stock Events

Stock Events

Acurx Pharmaceuticals 

$3.77
0
-$0.04-1.05% Today

Statistics

Day High
3.77
Day Low
3.76
52W High
-
52W Low
-
Volume
1,290
Avg. Volume
-
Mkt Cap
7.86M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2025
Q4 2025
Next
-1.31
-1.12
-0.92
-0.73
Expected EPS
-1.2
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
0Revenue
-28.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACXP.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that develops antibiotics and treatments for infectious diseases, directly competing with Acurx's focus on developing novel antibiotics.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including antibiotics, making it a competitor in the infectious disease space.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc engages in the creation and discovery of pharmaceutical products, including antibiotics, competing in the same market as Acurx Pharmaceuticals.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. researches and develops a broad range of pharmaceuticals including treatments for infectious diseases, positioning it as a competitor.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson engages in the research and development of pharmaceuticals, including those for infectious diseases, making it a competitor in the healthcare sector.
Novartis
NVS
Mkt Cap237.61B
Novartis AG focuses on the discovery, development, and marketing of healthcare products, including antibiotics, which places it in competition with Acurx.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. is a biotechnology company that develops innovative human therapeutics, including treatments for infections, competing in the biopharmaceutical space.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company discovers, develops, and delivers innovative medicines, including those for infectious diseases, competing with Acurx's product pipeline.
Sanofi
SNY
Mkt Cap124.45B
Sanofi engages in the research, development, and marketing of pharmaceutical products, including antibiotics, making it a direct competitor.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a global, science-led biopharmaceutical company that develops a range of pharmaceuticals, including those for bacterial infections, directly competing with Acurx Pharmaceuticals.

About

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Show more...
CEO
ISIN
US00510M2035

Listings

F
DE
3ZO0.F
XNAS
US
ACXP
BOATS
BOATS
ACXP.BOATS

0 Comments

Share your thoughts

FAQ

What is Acurx Pharmaceuticals stock price today?▼
The current price of ACXP.BOATS is $3.77 USD — it has decreased by -1.05% in the past 24 hours. Watch Acurx Pharmaceuticals stock price performance more closely on the chart.
What is Acurx Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Acurx Pharmaceuticals stocks are traded under the ticker ACXP.BOATS.
What is Acurx Pharmaceuticals market cap?▼
Today Acurx Pharmaceuticals has the market capitalization of 7.86M
When is the next Acurx Pharmaceuticals earnings date?▼
Acurx Pharmaceuticals is going to release the next earnings report on May 07, 2026.
What were Acurx Pharmaceuticals earnings last quarter?▼
ACXP.BOATS earnings for the last quarter are -0.73 USD per share, whereas the estimation was -1.01 USD resulting in a +27.96% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Acurx Pharmaceuticals revenue for the last year?▼
Acurx Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Acurx Pharmaceuticals net income for the last year?▼
ACXP.BOATS net income for the last year is -28.21M USD.
When did Acurx Pharmaceuticals complete a stock split?▼
Acurx Pharmaceuticals has not had any recent stock splits.